Melanoma Clinical Trial
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Summary
The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness of AU-011 and standard of care therapy. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.
Full Description
This is a multi-center long-term observational Registry of subjects with Primary Indeterminate Lesions or Choroidal Melanoma.
The Registry will initially be open to subjects who have previously participated in an Aura Biosciences bel-sar sponsored clinical trial for their primary Choroidal Melanoma or Indeterminate Lesions.
All subjects will be followed for a minimum of 5 years (including time enrolled in an Aura sponsored clinical trial), until withdrawal of consent, or until death whichever comes first.
No interventions will be required as part of the Registry. Data collection will be based on IL or CM information anticipated to be available based on the standard of care for subjects with CM or IL.
Eligibility Criteria
Inclusion Criteria:
Have been clinically diagnosed with primary IL or CM at the time of entry to a previous Aura Biosciences sponsored clinical trial.
Have received AU-011 bel-sar or assigned to a different cohort or treatment arm (sham, SoC, etc.) an observation cohort in a previous Aura sponsored clinical trial.
Exclusion Criteria:
- None
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 16 Locations for this study
Los Angeles California, 90095, United States More Info
Contact
Palo Alto California, 94303, United States More Info
Contact
Sacramento California, 95825, United States
Boston Massachusetts, 02114, United States More Info
Contact
Ann Arbor Michigan, 48105, United States More Info
Contact
Royal Oak Michigan, 48073, United States More Info
Contact
New York New York, 10032, United States More Info
Contact
Portland Oregon, 97239, United States More Info
Contact
Greenville South Carolina, 29605, United States More Info
Contact
Nashville Tennessee, 37203, United States More Info
Contact
How clear is this clinincal trial information?